iCorMicA - Stratified Medicine in Angina

NARecruitingINTERVENTIONAL
Enrollment

1,500

Participants

Timeline

Start Date

December 30, 2020

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2030

Conditions
Microvascular AnginaAngina, StableIschemia With No Obstructive Coronary Arteries (INOCA)Coronary Microvascular Dysfunction (CMD)Ischaemic Heart DiseaseNon-Obstructive Coronary AtherosclerosisCoronary Artery DiseaseVasospastic AnginaCoronary; IschemicAngina Attacks
Interventions
DIAGNOSTIC_TEST

Disclosure of IDP results

The results of the adjunctive IDP performed at time of invasive coronary angiography are made available to the catheter laboratory clinician, to aid in the diagnostic process.

OTHER

IDP performed but results not disclosed

The results of the IDP performed at the time of invasive coronary angiography are concealed from the catheter laboratory clinician who will be blinded. The patient is managed according to standard of care.

Trial Locations (2)

G814DY

RECRUITING

Golden Jubilee National Hospital, Clydebank

Unknown

NOT_YET_RECRUITING

NHS Greater Glasgow and Clyde, Glasgow

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University of Glasgow

OTHER

collaborator

Abbott Medical Devices

INDUSTRY

lead

NHS Greater Glasgow and Clyde

OTHER

NCT04674449 - iCorMicA - Stratified Medicine in Angina | Biotech Hunter | Biotech Hunter